Impact of Operational Theater on Combat and Noncombat Trauma-Related Infections

Abstract

The Trauma Infectious Disease Outcomes Study began in June 2009 as combat operations were decreasing in Iraq and increasing in Afghanistan. Our analysis examines the rate of infections of wounded U.S. military personnel from operational theaters in Iraq and Afghanistan admitted to Landstuhl Regional Medical Center between June 2009 and December 2013 and transferred to a participating U.S. hospital. Infection risk factors were examined in a multivariate logistic regression analysis (expressed as odds ratios [OR]; 95% confidence intervals [CI]). The study population includes 524 wounded military personnel from Iraq and 4,766 from Afghanistan. The proportion of patients with at least one infection was 28% and 34% from the Iraq and Afghanistan theaters, respectively. The incidence density rate was 2.0 (per 100 person-days) for Iraq and 2.7 infections for Afghanistan. Independent risk factors included large-volume blood product transfusions (OR: 10.68; CI: 6.73-16.95), high Injury Severity Score (OR: 2.48; CI: 1.81-3.41), and improvised explosive device injury mechanism (OR: 1.84; CI: 1.35-2.49). Operational theater (OR: 1.32; CI: 0.87-1.99) was not a risk factor. The difference in infection rates between operational theaters is primarily a result of increased injury severity in Afghanistan from a higher proportion of blast-related trauma during the study period.

Figure 1

Flow chart for disposition of patients admitted to Landstuhl Regional Medical Center (LRMC) between June 2009 and December 2013 with deployment-related injuries.

Figure 2

Flow chart for disposition of patients admitted to Landstuhl Regional Medical Center with deployment-related injuries sustained in the Iraq theater. Combat operations in Iraq (Operation Iraqi Freedom [OIF]) ended on August 31, 2010 and were followed by peacekeeping efforts (Operation New Dawn [OND]) which began on September 1, 2010 and ended on December 31, 2011.